Silicon Laboratories (Nasdaq: SLAB) reported earnings on July 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Silicon Laboratories beat expectations on revenue and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share expanded significantly.
Gross margins grew, operating margins contracted, and net margins improved.
Revenue details
Silicon Laboratories recorded revenue of $135.7 million. The 14 analysts polled by S&P Capital IQ predicted a top line of $132.1 million on the same basis. GAAP reported sales were 7.5% higher than the prior-year quarter's $126.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $0.51. The 16 earnings estimates compiled by S&P Capital IQ forecast $0.47 per share. GAAP EPS of $0.47 for Q2 were 62% higher than the prior-year quarter's $0.29 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 61.0%, 60 basis points better than the prior-year quarter. Operating margin was 12.1%, 60 basis points worse than the prior-year quarter. Net margin was 15.1%, 450 basis points better than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $139.1 million. On the bottom line, the average EPS estimate is $0.55.
Next year's average estimate for revenue is $537.4 million. The average EPS estimate is $2.01.
Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 355 members out of 382 rating the stock outperform, and 27 members rating it underperform. Among 123 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 117 give Silicon Laboratories a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Silicon Laboratories is outperform, with an average price target of $42.18.
Over the decades, small-cap stocks like Silicon Laboratories have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Silicon Laboratories to My Watchlist.
